Voss Capital, LP - Sep 24, 2025 SCHEDULE 13G/A Report for Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX)

Filing Manager
Voss Capital, LP
Reporting Manager
Voss Capital, LP
Security
Rein Therapeutics, Inc. Common Stock, $0.001 par value
Symbol
RNTX
Shares outstanding
23.6M shares
Disclosed Ownership
2.67M shares
Ownership
11.3%
Form type
SCHEDULE 13G/A
Date filed
9/26/2025, 06:46 PM
Date of event
Sep 24, 2025
Previous filing
May 14, 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Voss Value Master Fund, LP 3% 699K 699K 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner
Voss Value-Oriented Special Situations Fund, LP 1.3% 317K 317K 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner
Voss Advisors GP, LLC 4.3% 1.02M 1.02M 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member
Voss Capital, LP 11.3% 2.67M 2.67M 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member
Cocke Travis W. 11.3% 2.67M 2.67M 0 /s/ Travis W. Cocke Travis W. Cocke